Unified Protocol Versus Self-Acceptance Group Therapy for Emotional Disorders in People With Severe Shame

IF 3.2 3区心理学 Q1 PSYCHOLOGY, CLINICAL

Clinical psychology & psychotherapy Pub Date : 2024-06-24 DOI:10.1002/cpp.3022

Banafsheh Mohajerin, Richard C. Howard

{"title":"Unified Protocol Versus Self-Acceptance Group Therapy for Emotional Disorders in People With Severe Shame","authors":"Banafsheh Mohajerin, Richard C. Howard","doi":"10.1002/cpp.3022","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Severe shame is a distressing negative emotion, accompanied by intense feelings of worthlessness that contributes to a broad panoply of psychological disorders. This study aimed to compare the effects on shame dysregulation of two transdiagnostic treatments, the Unified Protocol (UP) and Self-Acceptance Group Therapy (SAGT). We additionally addressed the question of whether borderline personality disorder (BPD) can properly be regarded as an emotional disorder. The focus was on outcome measures, primarily shame that cut across individual diagnostic categories and capture emotional dysfunction broadly conceived.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Individuals suffering from a range of emotional disorders (including BPD) and high levels of shame were randomly allocated to treatment by either UP (<i>N</i> = 280) or SAGT (<i>N</i> = 282). Outcomes were measures of emotion dysfunction—shame, loneliness, neuroticism, emotional dysregulation, positive and negative affect—measured pre-treatment, post-treatment and at 3- and 6-month follow-ups.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>UP was superior to SAGT in showing better post-treatment retention of therapeutic gains on all outcome measures over the 6-month follow-up period. Compared with those without a BPD diagnosis, those diagnosed with BPD showed significantly higher neuroticism and emotion dysregulation at baseline and a similar post-treatment reduction in almost all outcomes.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The results support the use of both the UP and SAGT in the treatment of severe shame. The superiority of the UP over SAGT in reducing negative emotionality is interpreted in terms of the specific mechanisms targeted by the UP. The results provide support for the theoretical rationale for the UP as a treatment for dysregulated shame and for emotional dysfunction generally.</p>\n </section>\n </div>","PeriodicalId":10460,"journal":{"name":"Clinical psychology & psychotherapy","volume":"31 3","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical psychology & psychotherapy","FirstCategoryId":"102","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpp.3022","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Severe shame is a distressing negative emotion, accompanied by intense feelings of worthlessness that contributes to a broad panoply of psychological disorders. This study aimed to compare the effects on shame dysregulation of two transdiagnostic treatments, the Unified Protocol (UP) and Self-Acceptance Group Therapy (SAGT). We additionally addressed the question of whether borderline personality disorder (BPD) can properly be regarded as an emotional disorder. The focus was on outcome measures, primarily shame that cut across individual diagnostic categories and capture emotional dysfunction broadly conceived.

Methods

Individuals suffering from a range of emotional disorders (including BPD) and high levels of shame were randomly allocated to treatment by either UP (N = 280) or SAGT (N = 282). Outcomes were measures of emotion dysfunction—shame, loneliness, neuroticism, emotional dysregulation, positive and negative affect—measured pre-treatment, post-treatment and at 3- and 6-month follow-ups.

Results

UP was superior to SAGT in showing better post-treatment retention of therapeutic gains on all outcome measures over the 6-month follow-up period. Compared with those without a BPD diagnosis, those diagnosed with BPD showed significantly higher neuroticism and emotion dysregulation at baseline and a similar post-treatment reduction in almost all outcomes.

Conclusions

The results support the use of both the UP and SAGT in the treatment of severe shame. The superiority of the UP over SAGT in reducing negative emotionality is interpreted in terms of the specific mechanisms targeted by the UP. The results provide support for the theoretical rationale for the UP as a treatment for dysregulated shame and for emotional dysfunction generally.

查看原文本刊更多论文

统一方案与自我接纳团体疗法治疗严重羞耻感患者的情绪障碍。

背景：严重的羞耻感是一种令人痛苦的负面情绪，伴随着强烈的无价值感，会导致一系列心理障碍。本研究旨在比较统一方案（UP）和自我接纳团体疗法（SAGT）这两种跨诊断治疗方法对羞耻感失调的影响。此外，我们还探讨了边缘型人格障碍（BPD）是否可以适当地被视为情感障碍的问题。研究的重点是结果测量，主要是跨越个别诊断类别的羞耻感，以及广义上的情感功能障碍：方法：患有一系列情感障碍（包括 BPD）和高度羞耻感的患者被随机分配接受 UP（280 人）或 SAGT（282 人）治疗。结果是对情绪功能障碍--羞耻感、孤独感、神经质、情绪失调、积极和消极情绪--进行治疗前、治疗后以及3个月和6个月随访时的测量：在为期6个月的随访中，在所有结果测量中，UP在治疗后保持治疗成果方面优于SAGT。与未确诊为 BPD 的患者相比，确诊为 BPD 的患者在基线时表现出明显更高的神经质和情绪失调，治疗后几乎所有结果都有类似的下降：研究结果支持在治疗严重羞耻感时使用 UP 和 SAGT。在减少负面情绪方面，UP 比 SAGT 更胜一筹，这可以从 UP 所针对的特定机制来解释。研究结果为UP作为治疗羞耻感失调和一般情绪功能障碍的理论依据提供了支持。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical psychology & psychotherapy PSYCHOLOGY, CLINICAL-

CiteScore

6.30

自引率

5.60%

发文量

106

期刊介绍： Clinical Psychology & Psychotherapy aims to keep clinical psychologists and psychotherapists up to date with new developments in their fields. The Journal will provide an integrative impetus both between theory and practice and between different orientations within clinical psychology and psychotherapy. Clinical Psychology & Psychotherapy will be a forum in which practitioners can present their wealth of expertise and innovations in order to make these available to a wider audience. Equally, the Journal will contain reports from researchers who want to address a larger clinical audience with clinically relevant issues and clinically valid research.